Loading
HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.735
HK$0.00 · 0.00%
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Latest quote
HK$0.735
HK$0.00 · 0.00%
Regular session · HKT · Market data may be delayed.
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Day range
Current HK$0.735
52-week range
Current HK$0.735
Regular session · HKT · Market data may be delayed.
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Day range
Current HK$0.735
52-week range
Current HK$0.735
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.53B CNY | 2.71B CNY | 2.43B CNY | 2.2B CNY | 1.76B CNY |
| Cost of goods sold | 2.97B CNY | 2.19B CNY | 1.95B CNY | 2.12B CNY | 1.86B CNY |
| Gross profit | 559.44M CNY | 515.94M CNY | 487.41M CNY | 441.2M CNY | 262.74M CNY |
| Research and development | 36.32M CNY | 41.61M CNY | 41.53M CNY | 61.78M CNY | 45.95M CNY |
| Selling, general, and administrative | 550.23M CNY | 1.27B CNY | 374.54M CNY | 507.9M CNY | 325.84M CNY |
| Operating expenses | 546.02M CNY | 1.29B CNY | 539.3M CNY | 642.09M CNY | 415.56M CNY |
| Interest expense | 1.4M CNY | 2.24M CNY | 1.64M CNY | 1.17M CNY | 815K CNY |
| Depreciation and amortization | 3.53M CNY | 4.22M CNY | 20.32M CNY | 3.85M CNY | 2.89M CNY |
| Operating income | 13.42M CNY | −777.69M CNY | −51.9M CNY | −261.51M CNY | −195.92M CNY |
| Net income | 11.83M CNY | −854.89M CNY | −196.79M CNY | −383.3M CNY | −303.96M CNY |
Company facts updated Sep 11, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
